AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
48.24
-2.02 (-4.02%)
Oct 1, 2026, 3:07 PM EDT - Market open
AnaptysBio Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| 106.09 | 234.6 | 91.28 | 17.16 | 10.29 | |
Revenue Growth | -54.78% | 157.01% | 432.03% | 66.78% | -83.72% |
Cost of Revenue | -5.34 | -3.64 | 11.5 | 132.28 | 88.8 |
Gross Profit | 111.42 | 238.25 | 79.79 | -115.13 | -78.51 |
Selling, General & Admin | 45.73 | 11.35 | 13.63 | 41.95 | 36.64 |
Operating Expenses | 45.73 | 11.35 | 13.63 | 41.95 | 36.64 |
Operating Income | 65.7 | 226.9 | 66.15 | -157.07 | -115.15 |
Interest Expense | -82.38 | -79.89 | -50.09 | -18.08 | -21.11 |
Interest & Investment Income | 6.5 | 9.81 | 15.07 | 18.87 | 7.55 |
Currency Exchange Gain (Loss) | - | - | - | - | 0.01 |
Other Non Operating Income (Expenses) | -0 | 5.45 | - | -0 | - |
EBT Excluding Unusual Items | -10.19 | 162.28 | 31.14 | -156.28 | -128.7 |
Pretax Income | -10.19 | 162.28 | 31.14 | -163.62 | -128.7 |
Income Tax Expense | -362.9 | 0.77 | 0.16 | -0 | 0.02 |
Earnings From Continuing Operations | 352.72 | 161.5 | 30.98 | -163.62 | -128.72 |
Earnings From Discontinued Operations | -90.72 | -174.74 | -176.21 | - | - |
Net Income | 261.99 | -13.23 | -145.23 | -163.62 | -128.72 |
Net Income to Common | 261.99 | -13.23 | -145.23 | -163.62 | -128.72 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 29 | 29 | 28 | 27 | 28 |
Shares Outstanding (Diluted) | 37 | 30 | 30 | 27 | 28 |
Shares Change | 23.96% | 2.33% | 9.73% | -4.41% | 2.68% |
EPS (Basic) | 9.04 | -0.46 | -5.12 | -6.08 | -4.57 |
EPS (Diluted) | 7.00 | -0.44 | -4.91 | -6.08 | -4.57 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | -105.12 | 19.7 | -135.34 | -121.61 | -73.95 |
Free Cash Flow Per Share | -2.81 | 0.65 | -4.58 | -4.52 | -2.63 |
Gross Margin | 105.03% | 101.55% | 87.41% | - | - |
Operating Margin | 61.93% | 96.72% | 72.47% | -915.50% | -1119.41% |
Profit Margin | 246.96% | -5.64% | -159.11% | -953.66% | -1251.33% |
Free Cash Flow Margin | -99.09% | 8.40% | -148.27% | -708.79% | -718.88% |
EBITDA | 65.71 | 226.92 | 66.17 | -156.42 | -114.48 |
EBITDA Margin | 61.94% | 96.73% | 72.49% | - | - |
D&A For EBITDA | 0.02 | 0.02 | 0.02 | 0.65 | 0.68 |
EBIT | 65.7 | 226.9 | 66.15 | -157.07 | -115.15 |
EBIT Margin | 61.93% | 96.72% | 72.47% | - | - |
Effective Tax Rate | - | 0.48% | 0.51% | - | - |